Sepal International was a pioneer in initiating the concept of iron sucrose and nutritional infusion. Today, it is ranked amongst the leading companies in the therapeutic segment of parenteral infusion, cardiovascular (CV), gastro-intestinal (GI) and women healthcare (WHC). The company also has a significant presence in the hypertension, diabetology, gynaecology, oncology, allergy, pain management and anti-infective segments of healthcare.
Sepal International’s competitive advantage stems from its collaboration with world-class manufacturing companies, its extensive domestic network and a widespread presence in over five CIS countries.
